Works by Kee, Kwong‐Ming


Results: 51
    1
    2
    3
    4
    5
    6

    Five‐year comparative risk of hepatocellular carcinoma development under entecavir or tenofovir treatment‐naïve patients with chronic hepatitis B‐related compensated cirrhosis in Taiwan.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 11/12, p. 1695, doi. 10.1111/apt.16116
    By:
    • Hu, Tsung‐Hui;
    • Yueh‐Hsia Chiu, Sherry;
    • Tseng, Po‐Lin;
    • Chen, Chien‐Hung;
    • Lu, Sheng‐Nan;
    • Wang, Jing‐Houng;
    • Hung, Chao‐Hung;
    • Kee, Kwong‐Ming;
    • Lin, Ming‐Tsung;
    • Chang, Kuo‐Chin;
    • Lin, Meng‐Chih;
    • Chien, Rong‐Nan
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Hepatocellular Carcinoma Surveillance at 4- vs. 12-Month Intervals for Patients With Chronic Viral Hepatitis: A Randomized Study in Community.

    Published in:
    American Journal of Gastroenterology (Springer Nature), 2013, v. 108, n. 3, p. 416, doi. 10.1038/ajg.2012.445
    By:
    • Wang, Jing-Houng;
    • Chang, Kuo-Chin;
    • Kee, Kwong-Ming;
    • Chen, Pao-Fei;
    • Yen, Yi-Hao;
    • Tseng, Po-Lin;
    • Kuo, Yuan-Hung;
    • Tsai, Ming-Chao;
    • Hung, Chao-Hung;
    • Chen, Chien-Hung;
    • Tai, Wei-Chen;
    • Tsai, Lin-San;
    • Chen, Shu-Chuan;
    • Lin, Sheng-Che;
    • Lu, Sheng-Nan
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50